Disasters could disrupt care for opioid use disorder in most vulnerable communities

Rilzabrutinib for blood disorder shows promise in phase 1--2 clinical trial

Phase 3 clinical trial results lead to approval of oral drug for red blood cell disorder

About 1 in 4 adults has an often-missed liver disorder linked to higher heart disease risk